OmniStar Financial Group
COGT icon

OmniStar Financial Group’s Cogent Biosciences COGT Stock Holding History

OmniStar Financial Group’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$458K Hold
14,303
– – 0.2% 95
2026
Q2 		$554K Hold
14,303
– – 0.26% 94
2026
Q1 		$551K Hold
14,303
– – 0.29% 90
2025
Q4 		$508K Buy
+14,303
New +$402K 0.3% 72

Other funds holding COGT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 24.61% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.12B AUM 30.01% 1-Year Est. Return

OmniStar Financial Group's COGT Position: Q3 2026 in Review

OmniStar Financial Group held its Cogent Biosciences (COGT) position steady in Q3 2026 at 14,303 shares worth $458K. The position accounts for 0.2% of the portfolio, ranked #95.

OmniStar Financial Group first reported a position in COGT in Q4 2025 and has held it in 4 quarters since. The position peaked at $554K in Q2 2026. 87 funds tracked by Wall St. Rank hold COGT as of Q3 2026.

  • OmniStar Financial Group held 14,303 shares of Cogent Biosciences worth $458K as of Q3 2026.
  • OmniStar Financial Group left its Cogent Biosciences share count unchanged in Q3 2026.
  • Cogent Biosciences made up 0.2% of OmniStar Financial Group's portfolio in Q3 2026, its #95 holding.
  • OmniStar Financial Group first reported a position in Cogent Biosciences in Q4 2025 and has held it in 4 quarters since.
  • OmniStar Financial Group's Cogent Biosciences position peaked at $554K in Q2 2026.
  • 87 funds tracked by Wall St. Rank held Cogent Biosciences as of Q3 2026.

Based on OmniStar Financial Group's 13F filing for Q3 2026, filed 26 Oct 2026.